2019
DOI: 10.13040/ijpsr.0975-8232.10(2).966-72
|View full text |Cite
|
Sign up to set email alerts
|

Untitled

Abstract: Hypercholesterolemia is one of the major conditions that are prevalent in today's world, the significant causes being unhealthy food habits and lifestyle or abnormal genetic conditions. HMG CoA reductase is an important rate-limiting enzyme in the mevalonate pathway that synthesizes cholesterol. Biosynthesis of cholesterol in the liver can be reduced significantly by inhibiting HMG CoA reductase. Statins are the drugs used for the treatment of hypercholesterolemia. Due to the undesirable effects caused by synt… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 23 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?